Musely Hair Formula RxvsVegamour GRO Hair Serum

Musely Hair Formula Rx is a custom prescription that a compounding pharmacy makes after a telehealth provider reviews your photos and medical history. The topical "Hair Solution" (Classic) typically blends minoxidil 8% (widens scalp blood vessels and extends the follicle's growth phase), dutasteride (blocks both types of 5-alpha-reductase, the enzyme that creates DHT, the hormone that miniaturizes follicles in pattern hair loss), spironolactone (an additional anti-androgen), tretinoin (intended to boost minoxidil penetration), and ketoconazole plus hydrocortisone (to calm scalp inflammation and irritation). A "Modern" topical adds ingredients such as latanoprost, caffeine, and melatonin. The oral "Hair Pill" pairs low-dose oral minoxidil with dutasteride to suppress DHT systemically, and women's formulas may include spironolactone. The goal is to attack hair loss through multiple pathways at once. Note that Musely's topical uses dutasteride rather than finasteride; both block DHT, but dutasteride is more potent and has a much longer half-life.

GRO Hair Serum is a leave-in scalp tonic that works on the hair you still have rather than acting like a drug. Its plant actives are meant to support the follicle's growth (anagen) phase and a healthier scalp. Red clover and mung bean sprout extract supply isoflavones such as biochanin A, which in laboratory studies inhibit 5-alpha-reductase, the enzyme that converts testosterone to DHT (the hormone that miniaturizes follicles in pattern hair loss). Caffeine and turmeric-derived (curcumin) callus media are intended to support the scalp environment and reduce oxidative stress, while engineered Nicotiana benthamiana peptides (marketed as plant-derived signaling peptides or "exosomes") are meant to nudge follicles toward a more favorable state. Importantly, these mechanisms are demonstrated in lab and cell or animal models of individual ingredients, not in human trials of this finished serum. The intended effect is cosmetic: hair can look thicker and shed less, but the product does not claim to chemically force regrowth the way minoxidil or finasteride do.

The core actives are well-supported, though Musely's specific compounded formula has not been tested in its own published controlled trial, so efficacy is inferred from its ingredients rather than the branded product. Topical minoxidil is the only FDA-approved topical for androgenetic alopecia (oral finasteride and oral minoxidil's relatives aside, minoxidil is the topical standard): in the pivotal Olsen 2002 randomized trial of 393 men, 5% topical minoxidil produced a mean increase of about 18.6 non-vellus hairs/cm2 versus about 3.9 with placebo at 48 weeks, with roughly 60% of users rated improved on global photographic assessment versus about 23% on placebo. A 2025 systematic review and meta-analysis of 7 randomized trials (N=396) found topical minoxidil-finasteride combinations beat minoxidil alone, with a mean difference of about 9 more hairs/cm2 in density and significantly better global photographic assessment. A separate small 2025 RCT (N=40) found topical 0.1% finasteride plus 5% minoxidil performed about the same as minoxidil alone over a short 12-week window, a reminder that the added DHT-blocker benefit can take longer to show and that Musely's stronger dutasteride-based formula has not been individually validated.

The most-cited numbers come from Vegamour's own 120-day study of 40 participants using GRO Hair Serum once daily, described by the company as independent and third-party-conducted: up to 90% reduction in visible signs of shedding and up to a 56% increase in the appearance of hair density. These are company-sponsored, "appearance"-based cosmetic outcomes, not independently published, peer-reviewed regrowth data, and "up to" reflects best-case responders rather than the average. Independent support exists only at the ingredient level: a 2025 study in mice found that transferosome-delivered red clover extract and caffeine increased the proportion of follicles in the growth phase, with effects the authors called "comparable" to 2% minoxidil, but that tested the raw actives in a delivery vehicle, not this specific formula or human scalps. By contrast, FDA-approved minoxidil has independently published, controlled human-trial evidence, with meta-analyses reporting total hair-density gains on the order of roughly 7% to 15% (somewhat higher for oral than topical) and the 5% strength outperforming 2%. Real-world reviewers often report less shedding and somewhat fuller-looking hair after about three months, though many also change other hair habits at the same time, making results hard to attribute to the serum alone.

Common local effects from the topical include scalp itching, dryness, flaking, redness, stinging, and a temporary increase in shedding in the first 4-12 weeks. Minoxidil can cause unwanted facial hair if it migrates and, rarely, dizziness, fluid retention, or palpitations. The serious concern is the DHT blocker: in April 2025 the FDA issued a safety alert after receiving 32 reports (2019-2024) of systemic adverse events from compounded topical finasteride, including decreased libido, erectile dysfunction, depression, anxiety, suicidal ideation, brain fog, fatigue, and insomnia, some of which persisted after stopping. Musely's topical uses dutasteride rather than finasteride, but dutasteride is a more potent, longer-acting 5-alpha-reductase inhibitor and is also absorbed through the skin, so the same class of systemic risks reasonably applies and has not been ruled out. Spironolactone can cause menstrual changes, breast tenderness, and elevated potassium. Stop and seek medical care for mood changes, suicidal thoughts, chest pain, or breathing problems.

GRO is generally well tolerated and drug-free, so it avoids minoxidil's classic side effects (unwanted facial hair, an initial shedding phase, and rare blood-pressure-related concerns). The most common issues are mild and temporary: scalp tingling, slight redness, dryness, or a faintly oily feel as the scalp adjusts in the first few weeks. Less commonly, users report allergic-type reactions such as itching, swelling, or irritation, usually tied to a botanical or fragrance ingredient (the formula contains expressed bergamot peel oil and fragrance components such as limonene and linalool). Expressed bergamot peel oil can be phototoxic, so applying at night and limiting scalp sun exposure reduces any sun-sensitivity risk. Stop use and consult a clinician if you develop a persistent rash, significant irritation, or increased shedding. Patch-test first if you have sensitive or reactive skin.

As of 2026, Musely hair treatments are out-of-pocket; insurance generally does not cover compounded cosmetic-hair prescriptions, though FSA/HSA cards may be accepted. Expect roughly $95-$155 for a multi-month (about three-month) supply depending on the formula and whether you choose auto-refill (cheaper, advertised at up to ~30% off) or a one-time purchase, plus a one-time ~$20 doctor-visit fee that covers a one-year prescription and a 60-day consultation period. Auto-refill subscriptions can be paused or canceled before shipment at no cost. Musely advertises a 60-day money-back guarantee, but it generally does not apply to prescription hair treatments (which the company states are nonrefundable), so do not count on a refund for these products. Generic 5% minoxidil bought over the counter is far cheaper if you do not need the compounded combination.

As of 2026, a single 1 fl oz (30 mL) bottle, about a 30-day supply, runs roughly $64 at full retail (Vegamour.com, Sephora, Amazon). Multi-month bundles and the auto-ship subscription cut the effective price to roughly $39-$49 per month (often advertised as 20-47% off), and promotional sales appear frequently. Because it is a cosmetic, it is not covered by insurance, HSA/FSA eligibility is not guaranteed, and you must keep buying it indefinitely to maintain results, so plan on roughly $470-$770+ per year. For comparison, generic FDA-approved 5% minoxidil typically costs only about $10-$15 per month, which is worth weighing if budget is a priority.

Intended for adults with hormonal or pattern hair loss (androgenetic alopecia), general thinning, telogen effluvium, or postpartum shedding, after a clinician approves the prescription. It is not for scarring or autoimmune hair loss (e.g., alopecia areata), which need a different medical evaluation. Women who are pregnant, trying to conceive, or breastfeeding must avoid dutasteride and spironolactone (risk of harm to a developing fetus, including feminization of a male fetus), and tretinoin is also contraindicated in pregnancy; women should not even handle the dutasteride-containing products in these situations. Men concerned about sexual or mood side effects, and anyone with a history of depression or suicidal thoughts, should weigh the DHT-blocker risks carefully with the prescriber. People with low blood pressure, heart conditions, or kidney problems should flag minoxidil and spironolactone use, and you should always confirm a diagnosis with a clinician before starting.

Best for adults with early, mild, or diffuse thinning, postpartum shedding, or anyone wanting a vegan, hormone-free, drug-free way to improve the look and fullness of existing hair. It is not designed for advanced baldness or fully bare scalp areas, where no topical cosmetic can grow new follicles. Avoid or check with a clinician first if you are pregnant or breastfeeding (the serum contains expressed bergamot peel oil and biologically active plant isoflavones), have a known allergy to any listed botanical or fragrance, or have an irritated or broken scalp. Because expressed bergamot oil can be phototoxic, applying at night and protecting the scalp from sun is a sensible precaution. People with moderate-to-severe, patchy, or rapidly progressing loss should see a dermatologist for diagnosis and to discuss FDA-approved minoxidil or finasteride rather than relying on a cosmetic serum.